Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFavorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy
Transplant Infectious Disease, 09/11/09
Zhang FK et al. – The addition of ADV was efficient to treat LAM–resistant HBV. After 3 months of combination therapy, LAM was stopped and ADV monotherapy was continued. HBsAg seroconversion was achieved after an additional 12 months. The prevention and treatment of de novo HBV infection after OLT is discussed.
Fukui Zhang, 09/12/09
| It was a case report of de novo hepatitis B after liver transplantation because of end-stage primary biliary cirrhosis. Antiviral therapy with lamivudine/adefovir achieved favorable outcome of HBsAg clearance after 2 years. |
Related Articles
Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B
Hepatology, 11/18/09
Relevance Score: 91%
Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany
Journal of Clinical Virology, 11/16/09
Relevance Score: 91%
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 91%
Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09
Relevance Score: 91%
FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09
Relevance Score: 91%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme
HIV Medicine, 12/11/09
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09
Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics
Transplant Infectious Disease, 12/11/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients
Transplant Infectious Disease, 12/11/09
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection
Journal of Gastroenterology, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor